Skip to main content
. 2022 Jun 17;5(6):e2218323. doi: 10.1001/jamanetworkopen.2022.18323

Table 1. Baseline Characteristics of the Participants Before and After Propensity Score Matching.

Variables Participants, No (%)
Before matching After matching
Statin group (N = 1571) Non–statin group (N = 3534) Standardized mean difference Statin group (N = 1310) Non–statin group (N = 1310) Standardized mean difference
Age, mean (SD), y 64.2 (8.8) 59.3 (9.8) 0.53 64.6 (8.9) 61.9 (9.5) 0.29
Men 1182 (75.2) 2660 (75.3) −0.002 992 (75.7) 989 (75.5) 0.005
Women 389 (24.8) 874 (24.7) 0.002 318 (24.3) 321 (24.5) −0.005
BMI, mean (SD) 26.5 (3.2) 26.3 (3.4) 0.07 26.5 (3.2) 26.6 (3.4) −0.03
MAP, mean (SD), mm Hg 105.2 (13.2) 104.8 (14.0) 0.03 104.8 (13.3) 107.4 (14.5) −0.19
FBG, mean (SD), mg/dL 117.1 (45.0) 124.3 (52.3) −0.15 117.1 (46.8) 126.1 (52.3) −0.19
Triglyceride, mean (SD), mg/dL 194.7 (141.6) 185.8 (159.3) 0.02 194.7 (150.4) 194.7 (168.1) −0.02
LDL-C, mean (SD), mg/dL 92.7 (50.2) 96.5 (38.6) −0.09 92.7 (42.5) 96.5 (42.5) −0.08
HDL-C, mean (SD), mg/dL 57.9 (15.4) 54.1 (15.4) 0.02 57.1 (15.4) 56.4 (15.4) 0.05
Heart rate, mean (SD), bpm 73.9 (11.1) 74.9 (10.6) −0.09 73.7 (11.1) 74.8 (10.5) −0.10
Elevated hs-CRP (≥0.1 mg/dL) 1019 (64.9) 2159 (61.1) 0.08 845 (64.5) 852 (65.0) −0.01
High school or higher 420 (26.7) 929 (26.3) 0.01 343 (26.2) 381 (29.1) −0.07
Light salta 166 (10.6) 389 (11.0) −0.01 135 (10.3) 148 (11.3) −0.03
Current smoker 551 (35.1) 1244 (35.2) −0.003 465 (35.5) 438 (33.4) 0.04
Alcohol drinking 246 (15.7) 593 (16.8) −0.03 198 (15.1) 219 (16.7) −0.04
Physically activeb 316 (20.1) 607 (17.2) 0.08 265 (20.2) 250 (19.1) 0.03
Atherosclerotic risk factors
Hypertension 1480 (94.2) 2556 (72.3) 0.61 1219 (93.1) 1215 (92.8) 0.01
Diabetes 723 (46.0) 1433 (40.6) 0.11 605 (46.2) 652 (49.8) −0.07
Dyslipidemia 790 (50.3) 1758 (49.8) 0.01 659 (50.3) 654 (49.9) 0.01
Metabolic syndrome 691 (44.0) 1400 (39.6) 0.09 558 (42.6) 623 (47.6) −0.10
Obesity 498 (31.7) 1049 (29.7) 0.04 415 (31.7) 413 (31.5) 0.003
Concurrent drug treatment
Antihypertensive drug 1395 (88.8) 1135 (32.1) 1.42 1134 (86.6) 1132 (86.4) 0.004
Antidiabetic drug 634 (40.4) 1014 (28.7) 0.25 534 (40.8) 580 (44.3) −0.07

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); bpm, beats per minute; FBG, fasting blood glucose; HDL-C, high density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; MAP, mean arterial pressure.

SI conversion factor: to convert FBG to millimoles per liter, multiply by 0.0555; triglyceride to millimoles per liter, multiply by 0.0113; hs-CRP to milligrams per liter, multiply by 10; LDL-C and HDL-C to millimoles per liter, multiply by 0.0259.

a

A light salt was defined as less than 6 g/d according to the standard salt spoon in China.

b

Being physically active was defined as moderate or vigorous physical activity for at least 80 minutes per week.